Flash FinanceUS
After hours S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Aspen Neuroscience, Inc. (ASPE)

Aspen Neuroscience completes $140.6 million IPO at $15.00 per share

Neutral Impact 4 of 5 financing Written later

Aspen Neuroscience, Inc. completed its initial public offering on November 2, 2026, selling 9,375,000 shares of common stock at $15.00 per share. The company said gross proceeds were approximately $140.6 million, before underwriting discounts, commissions and offering expenses. Its amended and restated certificate of incorporation and bylaws also took effect on the same date.

Key points

  • IPO of 9,375,000 common shares at $15.00 per share, completed November 2, 2026
  • Gross proceeds of approximately $140.6 million, before underwriting discounts and offering expenses
  • Amended and restated certificate of incorporation and bylaws became effective at closing
  • Registration Statement on Form S-1 was filed October 9, 2026; final prospectus filed October 30, 2026

The filing

CompanyAspen Neuroscience, Inc. (ASPE)
Form8-K, current report
Filed with the SECNov 2, 2026, 4:49 PM ET
Accession number0001193125-26-443805

Items reported: 5.03 Bylaw / Charter Amendment8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:48 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 02, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.